InvestorsHub Logo
Followers 0
Posts 52
Boards Moderated 0
Alias Born 06/22/2006

Re: boston745 post# 19019

Wednesday, 09/12/2018 3:32:44 PM

Wednesday, September 12, 2018 3:32:44 PM

Post# of 41228
Looks like they will only be able to license Si3N4 for non-spinal indications since the gave exclusivity to CTL for 10 years.

From company SEC filing.
The Company will continue to manufacture the Silicon Nitride Products for CTL for ten years following the closing of the Transactions (the “Closing”) pursuant to an exclusive manufacturing arrangement described in the Purchase Agreement, and the Company will continue to manufacture and own all rights to silicon nitride products for other non-spinal biomedical applications (the “Amedica Products”)following the Closing. In addition, the Company will continue to own the patents claiming the manufacture of the Silicon Nitride Products and the Amedica Products and the related know how required for such manufacture.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News